yellow oil. (Rf 0.41 on SiO2, 5 : 1, CHCl3 : MeOH); [a]1D8 -0.2 (c
1.23, CHCl3); H NMR (CHCl3, 300 MHz, 300 K) d 13.66 (d,
(S)-2-[1-(4,4-Dimethyl-2,6-dioxo-cyclohexylidene)-ethylamino]-
6-[(3-hydroxy-propyl)-(2-nitrobenzenesulfonyl)-amino]-hexanoic
acid tert-butyl ester (7). Dde-L-Lys(Ns)-OtBu (6, 10.5 g, 19.0
mmol), K2CO3 (11.8 g, 85.7 mmol) and TBAI (0.1 g, 0.5 mmol)
were dissolved in DMF (75 mL) and heated up to 70 ◦C. At this
temperature 3-bromopropanol (2.1 mL, 24.8 mmol) was added
slowly. The mixture was stirred for 8 h at this temperature. H2O
(300 mL) was added and then the mixture was extracted with
EtOAc (2 ¥ 200 mL). The collected organic solvents were again
washed with brine (3 ¥ 150 mL). After drying over MgSO4 and
filtration, the organic solvents were removed in vacuo. The crude
product was purified by flash chromatography (SiO2, 10 : 0 → 4 : 1,
EtOAc–MeOH) to yield 7 (9.0 g, 78%) as a yellow oil. (Rf 0.25
1
1H, J = 7.5 Hz, 1H, NH), 7.95–7.89 (m, 2H, CH), 7.65–7.60 (m,
4H, CH), 7.57–7.53 (m, 2H, CH), 4.17 (app. q, 1H, J = 6.8 Hz,
Ha), 3.29–3.18 (m, 8H, CH2, He), 2.41 (s, 3H, CH3), 2.34 (s, 2H,
CH2), 2.28 (s, 2H, CH2), 2.23 (t, 2H, J = 7.2 Hz, CH2), 2.14
(s, 6H, CH3), 1.85–1.75 (m, 4H, CH2, Hb), 1.70–1.61 (m, 2H,
t
CH2), 1.55–1.46 (m, 2H Hd), 1.39 (s, 9H, Bu), 1.33–1.23 (m,
2H, Hg ), 0.96 (s, 6H, CH3); 13C NMR (CHCl3, 75 MHz) d 199.3
(C O), 196.8 (C O), 172.9 (C O), 169.1 (C), 147.9 (C), 133.6
(C), 132.9 (C), 131.8 (CH), 130.8 (CH), 130.6 (CH), 124.2 (CH),
124.1 (CH), 108.2 (C), 83.2 (C), 56.7 (CH2), 56.3 (CH), 53.6 (CH2),
52.2 (CH2), 47.4 (CH2), 46.0 (CH2), 45.3 (CH2), 45.1 (CH3), 45.0
(CH2), 32.2 (CH2), 30.0 (C), 28.4 (CH3), 28.2 (CH3), 27.9 (CH3),
27.6 (CH2), 26.0 (CH2), 22.2 (CH2), 18.2 (CH3); HRMS (ES) Calc.
for C40H59N6O12S2 879.3627, found 879.3632.
1
on SiO2, EtOAc); [a]D26 +2.5 (c 0.64, CHCl3); H NMR (CHCl3,
300 MHz, 300 K) d 13.63 (d, 1H, J = 7.5 Hz, NH), 7.93–7.89
(m, 1H, CH), 7.66–7.60 (m, 1H, CH), 7.58–7.54 (m, 1H, CH),
4.23–4.15 (m, 1H, Ha), 3.59 (t, 2H, J = 5.9 Hz, CH2OH), 3.34
(t, 2H, J = 7.0 Hz, NCH2), 3.22 (t, 2H, J = 7.3 Hz, He), 2.41 (s,
3H, CH3), 2.41 (bs, 2H, CH2), 2.28 (bs, 2H, CH2), 1.86–1.78 (m,
2H, CH2), 1.75–1.67 (m, 2H, Hb), 1.59–1.47 (m, 2H, Hd), 1.40 (s,
(S)-6-[{3-[(3-Dimethylamino-propyl)-(2-nitrobenzenesulfonyl)-
amino]-propyl}-(2-nitrobenzenesulfonyl)-amino]-2-[1-(4,4-dime-
thyl-2,6-dioxo-cyclohexylidene)-ethylamino]-hexanoic acid (10).
9 (615 mg, 0.69 mmol) was dissolved in CH2Cl2 (4.3 mL). TFA
(2.0 mL, 27.3 mmol) and Et3SiH (0.84 mL, 5.3 mmol) were added
and the resulting solution was stirred for 12 h at room temperature.
After evaporation of the solvent in vacuo and extraction of the
residue with CHCl3 (3¥) the product was dried under high vacuum
to yield 10 (655 mg, quant.) as a white foam. The product was
directly submitted to SPPS to avoid loss of the Dde-group.
t
9H, Bu), 1.37–1.27 (m, 2H, Hg ), 0.96 (s, 6H, CH3); 13C NMR
(CHCl3, 75 MHz) d 199.5 (C O), 197.1 (C O), 173.2 (C O),
169.1 (C), 148.2 (C), 133.7 (C), 133.2 (CH), 131.8 (CH), 130.7
(CH), 124.3 (CH), 108.5 (C), 83.4 (C), 59.3 (CH2), 56.9 (CH), 53.6
(CH2), 52.4 (CH2), 47.8 (CH2), 44.9 (CH2), 32.3 (CH2), 31.3 (CH2),
30.2 (C), 28.4 (CH3), 28.2 (CH2), 28.0 (CH3), 22.5 (CH2), 18.4
(CH3); HRMS (ES) Calc. for C29H43N3O9SNa 632.2612, found
632.2615.
General procedure for Fmoc Solid Phase Peptide Synthesis
N-(3-Dimethylamino-propyl)-2-nitrobenzenesulfonamide
(8).
To a solution of N,N-dimethyl-1,3-diaminopropane (6.3 mL,
50.0 mmol) and Et3N (6.7 mL, 50 mmol) in CH2Cl2 (100 mL) was
added Ns-Cl (5.54 g, 25.0 mol) in several portions. After addition
the resulting solution was stirred for 24 h. The mixture was
extracted with half saturated NaCl-solution (50 mL) and H2O
(50 mL). The organic phase was dried over Na2SO4, filtered and
the solvent was removed under high vacuum. The crude product
was purified by flash chromatography (SiO2, 5 : 1, CHCl3 : MeOH)
to yield 8 (6.21 g, 86%) as a yellow solid. (Rf 0.23 on SiO2, 5 : 1,
CHCl3 : MeOH); 1H NMR (CHCl3, 300 MHz, 300 K) d 8.05–8.00
(m, 1H, CH), 7.76–7.72 (m, 1H, CH), 7.59 (bs, 1H, NH), 3.11 (t,
2H, J = 5.9 Hz, CH2), 2.33 (t, 2H, J = 5.9 Hz, CH2), 2.16 (s, 6H,
CH3), 1.63 (app. qn, 2H, J = 5.9 Hz, CH2); 13C NMR (CHCl3,
75 MHz) d 148.1 (C), 133.8 (CH), 133.3 (CH), 132.4 (CH),
130.9 (CH), 125.0 (CH), 58.9 (CH2), 45.2 (CH3), 44.4 (CH2),
25.3 (CH2); HRMS (ES) Calc. for C11H18N3O4S 288.1013, found
288.1006.
Fmoc-protected amino acid (4.0 eq to resin loading), HOBt (4.0
eq) and HBTU (4.0 eq) were dissolved in DMF (5 mL) and
DIPEA (10.0 eq) was added. After five minutes pre-activation the
solution was transferred to the pre-swelled resin. 2-Chlorotrityl
chloride resin with a loading of 0.68 mmol g-1 was used for the
synthesis. The reaction was swirled for 2 h. Double coupling was
applied throughout the synthesis. After completion the solution
was drained and the resin washed with DMF (3¥), MeOH (3¥)
and CH2Cl2 (3¥). The completion of couplings was ascertained
by TNBS test. The Fmoc group was removed by treatment of the
pre-swelled resin with 20% piperidine in DMF (1 ¥ 10 min, 1 ¥
20 min).
Removal of Dde, Ns and final cleavage from the resin
A solution of 2% hydrazine in DMF (3 mL) was added to the
resin and swirled for 5 min. The washing step was repeated two
more times (1 ¥ 5 min, 1 ¥ 10 min). After deprotection the resin was
washed with DMF (3¥), MeOH (3¥) and CH2Cl2 (3¥). Coupling
of the following residue and Fmoc removal was done as described
above. Ns-cleavage was done by using 2-mercaptoethanol (20 eq)
and DBU (10 eq) for 30 min (3¥). After washing with DMF
(3¥), MeOH (3¥) and CH2Cl2 (3¥) the resin was dried under high
vacuum for 12 h. Final cleavage of the peptide from the resin was
done with 95 : 2.5 : 2.5 (TFA : TIPS : H2O) for 2 h. Filtration and
concentration of the filtrate in vacuo and precipitation with Et2O
yielded 1 (43 mg, 98%), 2 (44 mg, 97%), and 3 (37 mg, 86%),
respectively, as slightly yellow solids. 1: HRMS (ES) Calc. for
C32H65N10O8 717.4981, found 717.4984. 2: HRMS (ES) Calc. for
(S)-6-[{3-[(3-Dimethylamino-propyl)-(2-nitrobenzenesulfonyl)-
amino]-propyl}-(2-nitrobenzenesulfonyl)-amino]-2-[1-(2,4,4,6-
tetramethyl-cyclohexylidene)-ethylamino]-hexanoic acid tert-butyl
ester (9). PPh3 (2.51 g, 9.59 mmol) and DIAD (1.9 mL, 9.59
mmol) were dissolved in abs. THF (80 mL) at 0 ◦C. The mixture
was stirred until a precipitate was formed (15 min). To this
suspension was added 8 (2.43 g, 8.46 mmol) and stirred for another
20 min. After that time 7 (3.44 g, 5.64 mmol) in abs. THF (10 mL)
was slowly added via syringe. The mixture was warmed to room
temperature and stirred for 3 d. After evaporation of the solvent
in vacuo the crude product was purified by flash chromatography
(SiO2, 5 : 1, CHCl3 : MeOH). 9 (4.60 g, 93%) was obtained as a
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 5482–5486 | 5485
©